Cholesterol metabolism during cell growth: Which role for the plasma membrane?

European Journal of Lipid Science and Technology

Volumn 108, Issue 8, 2006, Pages 687-699

  Batetta, Barbara ^a,b   Sanna, Francesca ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b Sez Patologia Sperimentale   (Italy)

Author keywords

Cell proliferation; HDL C; Membrane cholesterol; Signal transduction

Indexed keywords

EID: 33748439501     PISSN: 14387697     EISSN: 14389312     Source Type: Journal    
DOI: 10.1002/ejlt.200600015     Document Type: Review

References (133)

1. M. S. Brown, J. L. Goldstein: Receptor-mediated endocytosis: Insights from the lipoprotein receptor system. Proc Natl Acad Sci USA. 1979, 76, 3330-3337.
2. K. E. Suckling, E. F. Stange: Role of acyl-CoA: Cholesterol acyltransferase in cellular cholesterol metabolism. J Lipid Res. 1985, 26, 647-671.
3. J. F. Oram, E. A. Brinton, L. Bierman: Regulation of high density lipoprotein receptor activity in cultured human skin fibroblast and human arterial smooth muscle cells. J Clin Invest. 1983, 72, 1611-1621.
4. Y. Lange, F. Strebel, T. L. Steck: Role of the plasmamembrane in cholesterol esterification in rat hepatoma cells. J Biol Chem. 1993, 268, 13838-13843.
5. L. Liscum, N. J. Munn: Intracellular cholesterol transport. Biochim Biophys Acta. 1999, 1438, 19-37.
6. F. R. Maxfield, D. Wustner: Intracellular cholesterol transport. J Clin Invest. 2002, 110, 891-898.
7. R. E. Soccio, J. L. Breslow: Intracellular cholesterol transport. Arterioscler Thromb Vasc Biol. 2004, 24, 1150-1160.
8. Y. Gong, J. N. Lee, P. C. Lee, J. L. Goldstein, M. S. Brown, J. Ye: Sterol-regulated ubiquitination and degradation of lnsig-1 creates a convergent mechanism for feedback control of cholesterol synthesis and uptake. Cell Metab. 2006, 3, 15-24.
9. J. L. Goldstein, R. A. DeBose-Boyd, M. S. Brown: Protein sensors for membrane sterols. Cell. 2006, 124, 35-46.
10. Y. Gong, J. N. Lee, M. S. Brown, J. L. Goldstein, J. Ye: Juxtamembranous aspartic acid in Insig-1 and Insig-2 is required for cholesterol homeostasis. Proc Natl Acad Sci USA. 2006, 103, 6154-6159.
11. H. W. Chen, A. A. Kandutsch, C. Waymouth: Inhibition of cell growth by oxygenated derivatives of cholesterol. Nature. 1974, 251, 419-421.
12. Y. Zhang, D. J. Mangelsdorf: LuXuRies of lipid homeostasis, the unit of nuclear hormone receptors, transcription regulation, and cholesterol sensing. Mol Interv. 2002, 2, 78-87.
13. P. Tontonoz, D. J. Mangelson: Liver X receptor signaling pathways in cardiovascular disease. Mol Endocrinol. 2003, 17, 985-993.
14. B. A. Janowski, P. J. Willy, T. R. Devi, J. R. Falck, D. J. Mangelsdorf: An oxysterol signalling pathway mediated by the nuclear receptor LXR alpha. Nature. 1996, 383, 728-731.
15. A. Venkateswaran, B. A. Laffitte, S. B. Joseph, P. A. Mak, D. C. Wilpitz, P. A. Edwards, P. Tontonoz: Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXR alpha. Proc Natl Acad Sci USA. 2000, 97, 12097-12102.
16. C. K. Glass: Going nuclear in metabolic and cardiovascular disease. J Clin Invest. 2006, 116, 556-560.
17. T. Yoshikawa, H. Shimano, M. Amemiya-Kudo, N. Yahagi, A. H. Hasty, T. Matsuzaka, H. Okazaki, Y. Tamura, Y. Iizuka, K. Ohashi, J. Osuga, K. Harada, T. Gotoda, S. Kimura, S. Ishibashi, N. Yamada: Identification of liver X receptor-retinoid X receptor as an activator of both the sterol regulatory element-binding protein 1c gene promoter. Mol Cell Biol. 2001, 21, 2991-3000.
18. T. Y. Chang, C. C. Chang, D. Cheng: Acyl-coenzyme A cholesterol acyltransferase. Annu Rev Biochem. 1997, 66, 613-638.
19. S. Miura, T. Chiba, N. Mochizuki, H. Nagura, K. Nemoto, I. Tomita, M. Ikeda, T. Tomita: Cholesterol-mediated changes of neutral cholesterol esterase activity in macrophages. Mechanism for mobilization of cholesteryl esters in lipid droplets by HDL. Arterioscler Thromb Vasc Biol. 1997, 17, 3033-3040.
20. R. G. W. Anderson: The caveolae membrane system. Annu Rev Biochem. 1998, 67, 199-225.
21. T. V. Kurzchalia, R. G. Parton: Membrane micradomains and caveolae. Curr Opin Cell Biol. 1999, 11, 424-431.
22. C. J. Fielding, A. Bist, P. E. Fielding: Caveolin mRNA levels are up-regulated by free cholesterol and down regulated by oxysterols in fibroblast monolayers. Proc Natl Acad Sci USA. 1997, 94, 3753-3758.
23. B. Razani, S. E. Woodman, M. P. Lisanti: Caveolae: from cell biology to animal physiology. Pharmacol Rev. 2002, 54, 431-467.
24. A. W. Cohen, R. Hnasko, W. Schubert, M. P. Lisanti: Role of caveolae and caveolins in health and disease. Physiol Rev. 2004, 84, 1341-1379.
25. K. Simons, D. Toomre: Lipid rafts and signal transduction. Nat Rev Mol Cell Biol. 2000, 1, 31-39.
26. T. Harder, K. R. Engelhardt: Membrane domains in lymphocytes - from lipid rafts to protein scaffolds. Traffic. 2004, 5, 265-275.
27. S. Munro: Lipid rafts: Elusive or illusive. Cell. 2003, 115, 377-388.
28. K. Simons, W. L. Vaz: Model systems, lipid rafts, and cell membranes. Annu Rev Biophys Biomol Struct. 2004, 33, 269-295.
29. C. J. Fielding, P. E. Fielding: Cholesterol and caveolae: Structural and functional relationship. Biochem Biophys Acta. 2000, 1529, 210-222.
30. A. Brooks-Wilson, M. Marcil, S. M. Clee, L. H. Zhang, K. Roomp, M. van Dam, L. Yu, C. Brewer, J. A. Collins, H. O. Molhuizen, O. Loubser, B. F. Ouelette, K. Fichter, K. J. Ashbourne-Excoffon, C. W. Sensen, S. Scherer, S. Mott, M. Denis, D. Martindale, J. Frohlich, K. Morgan, B. Koop, S. Pimstone, J. J. Kastelein, J. Jr. Genest, M. R. Hayden: Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency. Nat Genet. 1999, 22, 336-345.
31. G. A. Graf, P. M. Connell, D. R. van der Westhuyzen, E. J. Smart: The class B, type 1 scavenger receptor promotes the selective uptake of high density lipoprotein cholesterol esters into caveolae. J Biol Chem. 1999, 274, 12043-12048.
32. S. L. Acton, K. F. Kozarsky, A. Rigotti: The HDL receptor SR-BI: A new therapeutic target for atherosclerosis? Mol Med Today. 1999, 5, 518-524.
33. Y. Lange, T. L. Steck: Cholesterol homeostasis modulation by amphiphiles. J Biol Chem. 1994, 269, 29371-29374.
34. P. Debry, D. W. Neklason, J. E. Metherall: Role of multidrug resistance P-glycoproteins in cholesterol esterification. J Biol Chem. 1997, 272, 1026-1031.
35. G. D. Luker, K. R. Nilsson, D. F. Covey, D. Piwnica-Worms: Multidrug resistance (MDR1) P-glycoprotein enhances esterification of plasma membrane cholesterol. J Biol Chem. 1999, 274, 6979-6991.
36. S. V. Ambudkar, S. Dey, C. A. Hrycyna, M. Ramachandra, I. Pastan, M. M. Gottesman: Biochemical, cellular, and pharmacological aspects of the multidrug transporter. Annu Rev Pharmacol Toxicol. 1999, 39, 361-398.
37. M. M. Gottesman: How cancer cells evade chemotherapy. Sixteenth Richard and Hinda Rosenthal Foundation Award Lecture. Cancer Res. 1993, 53, 747-754.
38. W. T. Bellamy: P-glycoproteins and multidrug resistance. Annu Rev Pharmacol Toxicol. 1996, 36, 161-182.
39. R. P. Van Hoeven, P. Emmelot: Studies on plasma membrane. 18. Lipid class composition of plasma membrane isolated from rat and mouse liver and hepatomas. J Membr Biol. 1972, 9, 105-126.
40. D. E. Brenneman, S. N. Mathur, A. A. Spector: Characterisation of the hyperlipidemia in mice bearing the Earlich ascites tumor. Eur J Cancer. 1975, 11, 225-230.
41. J. R. Sabine: Defective control of lipid biosynthesis in cancerous and precancerous liver. Prog Biochem Pharmacol. 1975, 10, 269-307.
42. P. L. Pedersen: Tumor mitochondria and the biogenesis of cancer cells. Prog Exp Tumor Res. 1978, 22, 190-274.
43. N. I. Azrolam, P. S. Coleman: A discoordinate increase in the cellular amount of 3-hydroxy-3-methylglutaryl-CoA reductase results in the loss of rate-limiting control over cholesterogenesis in a tumor cell-free system. Biochem J. 1989, 258, 421-425.
44. S. Dessi, B. Batetta: Cholesterol metabolism in human tumors. In: Cell Growth and Cholesterol Esters. Eds. A. Pani, S. Dessi, Kluwer Academic/Plenum Publishers, New York (USA) 2004, pp. 35-47.
45. M. R. Tosi, V. Tugnoli: Cholesteryl esters in malignancy. Clin Chim Acta. 2005, 359, 27-45.
46. H. W. Chen, H. J. Heiniger, A. A. Kanduch: Relationship between sterol synthesis and DNA synthesis in phytohemagglutinin-stimulated mouse lymphocytes. Proc Natl Acad Sci USA. 1975, 72, 1950-1954.
47. A. J. R. Habenicht, J. A. Glomset, R. Ross: Relation of cholesterol and mevalonic acid to cell cycle in smooth muscle and Swiss 3T3 cells stimulated to divide by platelet-derived growth factor. J Biol Chem. 1981, 255, 5134-5140.
48. A. Endo, M. Kuroda, K. Tanzawa: Competitive inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase by ML-236A and ML-236B, fungal metabolites, having hypocholesterolemic activity. FEBS Lett. 1976, 72, 323-326.
49. A. Endo: The discovery and development of HMG-CoA reductase inhibitors. J Lipid Res. 1992, 33, 1569-1582.
50. R. A. Schmidt, C. J. Schneider, J. A. Glomset: Evidence for post-translational incorporation of a product of mevalonic acid into Swiss 3T3 cell proteins. J Biol Chem. 1984, 259, 10175-10180.
51. M. D. Siperstein: Role of cholesterogenesis and isoprenoid synthesis in DNA replication and cell growth. J Lipid Res. 1984, 25, 1462-1468.
52. F. L. Zhang, P. J. Casey: Protein prenylation: Molecular mechanism and functional consequences. Annu Rev Biochem. 1996, 65, 241-269.
53. M. Sinensky: Recent advances in the study of prenylated proteins. Biochim Biophys Acta. 2000, 1484, 93-106.
54. P. S. Coleman, L. C. Chen, L. Sepp-Lorenzino: Cholesterol metabolism and tumor cell proliferation. Subcell Biochem. 1997, 28, 363-435.
55. S. Dessì: Role of mevalonate derivatives in cell cycle progression. In: Cell Growth and Cholesterol Esters. Eds. A. Pani, S. Dessi, Kluwer Academic/Plenum Publishers, New York (USA) 2004, pp. 13-24.
56. K. K. Chan, A. Oza, L. L. Siu: The statins as anticancer agents. Clinical Cancer Res. 2003, 9, 10-19.
57. J. Pan, S. C. Yeung: Recent advances in understanding the antineoplastic mechanisms of farnesyltransferase inhibitors. Cancer Research. 2005, 65, 9109-9112.
58. M. J. Oppenheimer, J. F. Oram, E. L. Bierman: Downregulation of high density lipoprotein receptor activity of cultured fibroblasts by platelet-derived growth factor. Atherosclerosis. 1987, 7, 325-332.
59. B. Batetta, R. R. Bonatesta, F. Sanna, M. Putzolu, M. F. Mulas, M. Collu, S. Dessi: Cell growth and cholesterol metabolism in human glucose-6-phosphate dehydrogenase deficient lymphomononuclear cells. Cell Prolif. 2002, 35, 143-154.
60. J. F. Oram, A. J. Mendez, J. Lymp, T. J. Kavanagh, C. L. Halbert: Reduction in apolipoprotein-mediated removal of cellular lipids by immortalization of human fibroblasts and its reversion by cAMP: Lack of effect with Tangier disease cells. J Lipid Res. 1999, 40, 1769-1781.
61. H. S. Gilbert, H. Ginsberg, R. Fagerstrom, W. V. Brown: Characterization of hypocholesterolemia in myeloproliferative disease. Relation to disease manifestations and activity. Am J Med. 1981, 71, 595-602.
62. H. N. Ginsberg, N. A. Le, H. S. Gilbert: Altered high density lipoprotein metabolism in patients with myeloproliferative disorders and hypocholesterolemia. Metabolism. 1986, 35, 878-882.
63. S. Dessi, B. Batetta, O. Spano, F. Sanna, M. Tonello, M. Giacchino, L. Tessitore, R Costelli, F. M. Baccino, E. Madon, P. Pani: Clinical remission is associated with restoration of normal high-density lipoprotein cholesterol levels in children with malignancies. Clin Sci. 1995, 89, 505-510.
64. J. M. Halton, D. J. Nazir, M. J. McQeen, R. D. Barr: Blood lipid profiles in children with acute lymphoblastic leukaemia. Cancer. 1998, 83, 379-384.
65. A. Cantafora, I. Blotta: Neutral lipids production, transport, utilization. Anticancer Res. 1996, 16, 1441-1449.
66. S. Dessi, C. Chiodino, B. Batetta, A. M. Fadda, C. Anchisi, P. Pani: Hepatic glucose-6-phosphate dehydrogenase, cholesterogenesis, and serum lipoproteins in liver regeneration after partial hepatectomy. Exp Mol Pathol. 1986, 44, 169-176.
67. S. Dessi, B. Batetta, E. Laconi, C. Ennas, P. Pani: Hepatic cholesterol in lead nitrate induced liver hyperplasia. Chem Biol Inter. 1984, 48, 271-279.
68. S. Dessì, B. Batetta, A. Carrucciu, D. Pulisci, S. Laconi, A. M. Fadda, C. Anchisi, P. Pani: Variations of serum lipoprotein during cell proliferation induced by lead nitrate. Exp Mol Pathol. 1989, 51, 97-102.
69. S. Dessì, C. Chiodino, B. Batetta, M. Armeni, M. F. Mulas, P. Pani: Comparative effects of insulin and refeeding on DNA synthesis, HMP-shunt and cholesterogenesis in diabetic and fasted rats. Pathology. 1988, 20, 53-57.
70. S. Dessì, B. Batetta, D. Pulisci, A. Carrucciu, E. Mura, A. Ferreli, P. Pani: Modifying influence of fasting on liver hyperplasia induced by lead nitrate. Res Commun Chem Pathos Pharmacol. 1990, 68, 103-116.
71. G. M. Ledda-Columbano, A. Columbano, S. Dessi, P. Coni, C. Chiodino, P. Pani: Enhancement of cholesterol synthesis and pentose phosphate pathway activity in proliferating hepatocyte nodules. Carcinogenesis. 1985, 6, 1371-1373.
72. S. Dessì, B. Batetta, C. Anchisi, P. Pani, P. Costelli, L. Tessitore, F. M. Baccino: Cholesterol metabolism during the growth of a rat ascites hepatoma (Yoshida AH-130). Br J Cancer. 1992, 66, 787-793.
73. G. M. Ledda Columbano, A. Columbano, S. Dessì, R Coni, C. Chiodino, G. Faa, P. Pani: Hexose monophosphate shunt and cholesterogenesis in lead induced-kidney hyperplasia. Chem Biol Inter. 1987, 62, 209-215.
74. S. Dessì, B. Batetta, O. Spano, D. Pulisci, C. Anchisi, P. Pani, G. Broccia: Serum lipoprotein during bone marrow hyperplasia after phenylhydrazine administration in rats. Int J Exp Pathol. 1990, 71, 671-675.
75. S. Dessì, B. Batetta: Cholesterol esters and cell growth; coregulation in animal models. In: Cell Growth and Cholesterol Esters. Eds. A. Pani, S. Dessì, Kluwer Academic/Plenum Publishers, New York (USA) 2004, pp. 25-34.
76. K. N. Rao, S. Kottapally, E. D. Eskander, H. Shinozuka, S. Dessi, P. Pani: Acinar cell carcinoma of rat pancreas: Regulation of cholesterol esterification. Br J Cancer. 1986, 54, 305-310.
77. F. Sanna, M. Putzolu, B. Batetta: Cholesterol esters and cell growth in human lymphocytes: Possible implication of P-gp modulators. In: Cell Growth and Cholesterol Esters. Eds. A. Pani, S. Dessì, Kluwer Academic/Plenum Publishers, New York (USA) 2004, pp. 65-71.
78. B. Batetta, M. F. Mulas, F. Sanna, M. Putzolu, R. R. Bonatesta, A. Gasperi-Campani, L. Roncuzzi, D. Baiocchi, S. Dessì: Role of cholesterol ester pathway in the control of cell cycle in human aortic smooth muscle cells. FASEB J. 2003, 17, 746-748.
79. B. Batetta, A. Pani, M. Putzolu, F. Sanna, R. R. Bonatesta, S. Piras, O. Spano, M. F. Mulas, S. Dessì: Correlation between cholesterol esterification, MDR1 gene expression and rate of cell proliferation in CEM and MOLT4 cell lines. Cell Prolif. 1999, 32, 49-61.
80. S. Dessì, B. Batetta, A. Pani, O. Spano, F. Sanna, M. Putzolu, R. R. Bonatesta, S. Piras, P. Pani: Role of cholesterol synthesis and esterification in the growth of CEM and MOLT4 lymphoblastic cells. Biochem J. 1997, 321, 603-608.
81. S. Dessì, F. Sanna, R. R. Bonatesta, M. F. Mulas, M. Putzolu, S. Piras, O. Spano, A. Pani, B. Batetta: Growth regulation of L1210 leukemic cells: Role of cholesterol esterification. Atherosclerosis. 1997, 135, S12.
82. D. Sviridov, P. Nestel: Dynamics of reverse cholesterol transport: Protection against atherosclerosis. Atherosclerosis. 2002, 161, 245-254.
83. S. Dessì, B. Batetta, D. Pulisci, O. Spano, C. Anchisi, L. Tessitore, P. Costelli, F. M. Baccino, E. Aroasio, P. Pani: Cholesterol content in tumor tissues is inversely associated with high density lipoprotein cholesterol in serum in patients with gastrointestinal cancer. Cancer. 1994, 15, 253-258.
84. C. Anchisi, B. Batetta, F. Sanna, A. M. Fadda, A. M. Maccioni, S. Dessì: HDL subfractions as altered in cancer patients. J Pharm Biomed Anal. 1995, 13, 65-71.
85. B. Batetta, S. Dessì, D. Pulisci, O. Spano, C. Anchisi, P. Pani: Effect of chlorpromazine on cholesterol metabolism during liver hyperplasia induced by lead nitrate. Res Commun Psychol Psychiatr Behav. 1991, 16, 155-165.
86. G. W. Cockerill, K. A. Rye, J. R. Gamble, M. A. Vadas, P. J. Barter: High-density lipoproteins inhibit cytokine-induced expression of endothelial cell adhesion molecules. Arterioscler Thromb Vasc Biol. 1995, 15, 1987-1994.
87. P. Xia, M. A. Vadas, K. A. Rye, P. J. Barter, J. R. Gamble: High density lipoproteins (HDL) interrupt the sphingosine kinase signaling pathway. A possible mechanism for protection against atherosclerosis by HDL. J Biol Chem. 1999, 274, 33143-33147.
88. R. Moudry, M. O. Spycher, J. E. Doran: Reconstituted high density lipoprotein modulates adherence of polymorphonuclear leukocytes to human endothelial cells. Shock. 1997, 7, 175-181.
89. Y. Matsuda, K. Hirata, N. Inoue, M. Suematsu, S. Kawashima, H. Akita, M. Yokoyama: High density lipoprotein reverses inhibitory effect of oxidized low density lipoprotein on endothelium-dependent arterial relaxation. Circ Res. 1993, 72, 1103-1109.
90. J. Galle, M. Ochslen, P. Schollmeyer, C. Wanner: Oxidized lipoproteins inhibit endothelium-dependent vasodilatation. Effects of pressure and high density lipoprotein. Hypertension. 1994, 23, 556-564.
91. A. Uttenbogaard, P. W. Shaul, I. S. Yuhanna, A. Blair, E. J. Smart: High density lipoprotein prevents oxidized low density lipoprotein-induced inhibition of endothelial nitric-oxide synthase localization and activation in caveolae. J Biol Chem. 2000, 275, 11278-11283.
92. T. W. Meade, V. Ruddock, Y. Stirling, R. Chakrabarti, G. J. Miller: Fibrinolitic activity, clotting factors, and long-term incidence of ischaemic heart disease in the Northwick Park Heart Study. Lancet. 1993, 342, 1076-1079.
93. A. Oseroff, C. Krishnamurti, A. Hassett, D. Tang, B. Alving: Plasminogen activator and plasminogen activator inhibitor activities in men with coronary artery disease. J Lab Clin Med. 1989, 113, 88-93.
94. J. H. Griffin, K. Kojima, C. L. Banka, L. K. Curtiss, J. A. Fernandez: High-density lipoprotein enhancement of anticoagulant activities of plasma lipoprotein S and activated protein C. J Clin Invest. 1999, 103, 219-227.
95. D. Pajkrt, P. G. Lerch, T. Van der Poll, M. Levi, M. Illi, J. E. Doran, B. Arnet, A. Van den Ende, J. W. Ten Cate, S. J. Van Deventer: Differential effects of reconstituted high-density lipoprotein on coagulation, fibrinolysis and platelet activation during human endotoxemia. Thromb Haemost. 1997, 77, 303-307.
96. T. Kaneko, H. Wada, Y. Wakita, K. Minamikawa, T. Nakase, Y. Mori, K. Deguchi, S. Shirakawa: Enhanced tissue factor activity and plasminogen activator inhibitor-1 antigen in human umbilical vein endothelial cells incubated with lipoproteins. Blood Coagul Fibrinolysis. 1994, 5, 385-392.
97. R. M. Lawn, D. P. Wade, M. R. Garvin, X. Wang, K. Schwartz, J. G. Porter, J. J. Seilhamer, A. M. Vaughan, J. F. Oram: The Tangier disease gene product ABCA1 controls the cellular apolipoprotein mediated lipid removal pathway. J Clin Invest. 1999, 104, 1015-1017.
98. E. Orso, C. Broccardo, W. E. Kaminski, A. Bottcher, G. Liebisch, W. Drobnik, A. Gotz, O. Chambenoit, W. Diederich, T. Langmann, T. Spruss, M. F. Luciani, G. Rothe, K. J. Lackner, G. Chimini, G. Schmitz: Transport of lipids from Golgi to plasma membrane is defective in tangier disease patients and Abc1-deficient mice. Nat Genet. 2000, 24, 192-196.
99. G. Schmitz, T. Langmann: Structure, function and regulation of the ABC1 gene product. Curr Opin Lipidol. 2001, 12, 129-140.
100. T. Langmann, J. Klucken, M. Reil, G. Liebisch, M. F. Luciani, G. Chimini, W. E. Kaminski, G. Schmitz: Molecular cloning of the human ATP-binding cassette transporter 1 (hABC1): Evidence for sterol-dependent regulation in macrophages. Biochem Biophys Res Commun. 1999, 257, 29-33.
101. G. Schmitz, T. Langmann: Transcriptional regulatory networks in lipid metabolism control ABCA1 expression. Biochim Biophys Acta. 2005, 1735, 1-19.
102. J. Klucken, C. Buchler, E. Orso, W. E. Kaminski, M. Porsch-Ozcurumez, G. Liebisch, M. Kapinsky, W. Diederich, W. Drobnik, M. Dean, R. Allikmets, G. Schmitz: ABCG1 (ABC8), the human homolog of the Drosophila white gene, is a regulator of macrophage cholesterol and phospholipid transport. Proc Natl Acad Sci USA. 2000, 97, 817-822.
103. G. Schmitz, T. Langmann, S. Heimerl: Role of ABCG1 and other ABCG family members in lipid metabolism. J Lipid Res. 2001, 42, 1513-1520.
104. J. E. Wu, F. Basso, R. D. Shamburek, M. J. A. Amar, B. Vaisman, G. Szakacs, C. Joyce, T. Tansey, L. Freeman, B. J. Paigen, F. Thomas, H. B. Jr. Brewer, S. Santamarina-Fojo: Hepatic ABCG5/ABCG8 overexpression increases hepatobiliary sterol transport but does not alter aortic atherosclerosis in transgenic mice. J Biol Chem. 2004, 279, 22913-22925.
105. T. Janvilisri, H. Venter, S. Shahi, G. Reuter, L. Balakrishnan, H. W. Van Veen: Sterol transport by the human breast cancer resistance protein (ABCG2) expressed in Lactococcus lactis. J Biol Chem. 2003, 278, 20645-20651.
106. M. Krieger: Charting the fate of the "good cholesterol": Identification and characterization of the high-density lipoprotein receptor SR-B1. Annu Rev Biochem. 1999, 68, 523-558.
107. G. Jurgens, Q. Xu, L. A. Huber, G. Bock, H. Howanietz, G. Wick, K. N. Traill: Promotion of lymphocyte growth by high density lipoproteins (HDL). Physiological significance of the HDL binding site. J Biol Chem. 1989, 264, 8549-8556.
108. M. Walter, H. Reinecke, J. R. Nofer, U. Seedorf, G. Assman: HDL3 stimulates multiple signaling pathways in human skin fibroblasts. Arterioscler Thromb Vasc Biol. 1995, 15, 1975-1986.
109. J. R. Nofer, M. Fobker, G. Hobbel, R. Voss, I. Wolinska, M. Tepel, W. Zidek, R. Junker, U. Seedorf, A. Von Eckardstein, G. Assmann, M. Walter: Activation of phosphatidylinositol-specific phospholipase C by HDL-associated lysosphingolipid. Involvement in mitogenesis but not in cholesterol efflux. Biochemistry. 2000, 39, 15199-15207.
110. J. R. Nofer, R. Junker, E. Pulawski, M. Fobker, B. Levkau, A. Von Eckardstein, U. Seedorf, G. Assman, M. Walter: High density lipoproteins induce cell cycle entry in vascular smooth muscle cells via mitogen activated protein kinase-dependent pathway. Thromb Haemost. 2001, 85, 730-735.
111. T. Kimura, K. Saro, E. Malchinkhuu, H. Tomura, K. Tamama, A. Kuwabara, M. Murakami, F. Okajima: High density lipoprotein stimulates endothelial cell migration and survival through sphingosine-1-phosphate and its receptors. Atheroscler Thromb Vasc Biol. 2003, 23, 1283-1288.
112. J. P. Slotte, E. L. Bierman: Depletion of plasma-membrane sphingomyeline rapidly alters the distribution of cholesterol between plasma-membranes and intracellular cholesterol pools in cultured fibroblasts. Biochem J. 1988, 250, 653-658.
113. M. P. Lisanti, P. E. Scherer, Z. L. Thang, M. Sargiacomo: Caveolae, caveolin and caveolin-rich membrane domains: A signalling hypothesis. Trends Cell Biol. 1994, 4, 231-235.
114. M. P. Lisanti, Z. T. Tang, P. E. Scherer, M. Sargiacomo: Caveolae purification and glycosylphosphatidylinositol-linked protein sorting in polarized epithelia. Methods Enzymol. 1995, 250, 665-668.
115. A. W. Cohen, R. Hansko, W. Schubert, M. P. Lisanti: Role of caveolae and caveolins in health and disease. Physiol Rev. 2004, 84, 1341-1379.
116. J. A. Engelman, C. C. Wycoff, S. Yasuhara, K. S. Song, T. Okamoto, M. P. Lisanti: Recombinant expression of caveolin-1 in oncogenically transformed cells abrogates anchorage-independent growth. J Biol Chem. 1997, 272, 16374-16381.
117. C. J. Fielding, A. Bist, P. E. Fielding: Intracellular cholesterol transport in synchronized human skin fibroblasts. Biochemistry. 1999, 38, 2506-2513.
118. C. J. Fielding, P. E. Fielding: Membrane cholesterol and the regulation of signal transduction. Biochem Soc Trans. 2004, 32, 65-69.
119. M. A. Alonso, J. Millan: The role of lipid rafts in signalling and membrane trafficking in T lymphocytes. J Cell Sci. 2001, 114, 3957-3965.
120. M. Liscovitch, Y. Lavie: Multidrug resistance: A role for cholesterol efflux pathways? Trends Biochem Sci. 2000, 25, 530-534.
121. K. Jones, P. G. Bray, S. H. Khoo, R. A. Davey, E. R. Meaden, S. A. Ward, D. J. Back: P-Glycoprotein and transporter MRP1 reduce HIV protease inhibitor uptake in CD4 cells: Potential for accelerated viral drug resistance? AIDS. 2001, 15, 1353-1358.
122. + T lymphoblastoid CEM cell line. Chemotherapy. 2003, 49, 8-16.
123. Y. Lange, T. L. Steck: Quantitation of the pool of cholesterol associated with acyl-CoA:cholesterol acyltransferase in human fibroblasts. J Biol Chem. 1997, 272, 13103-13108.
124. M. Issadou, T. Grand-Perret: Multidrug resistance P-glycoprotein is not involved in cholesterol esterification. Biochem Biophys Res Commun. 2000, 279, 369-377.
125. R. W. Johnstone, A. A. Ruefli, M. J. Smyth: Multiple physiological functions for multidrug transporter P-glycoprotein. Trends Biochem Sci. 2000, 25, 1-6.
126. K. D. Bunting, J. Galipeau, D. Topham, E. Benaim, B. P. Sorrentino: Transduction of murine bone marrow cells with an MDR1 vector enables ex vivo stem cells expansion, but these expanded grafts cause a myeloproliferative syndrome in transplanted mice. Blood. 1998, 92, 2269-2279.
127. P. M. Chaudhary, E. B. Mechetner, I. B. Roninson: Expression and activity of the multidrug resistance P-glycoprotein in human peripheral blood lymphocytes, Blood. 1992, 80, 2735-2739.
128. D. Israeli, S. Ziaei, P. Gonin, L. Garcia: A proposal for the physiological significance of mdr1 and Bctp1/Abcg2 gene expression in normal tissue regeneration and after cancer therapy. J Theor Biol. 2005, 232, 41-45.
129. H. Nakatsukasa, J. A. Silverman, T. W. Gant, R. P. Evarts, S. S. Thorgeirsson: Expression of multidrug resistance genes in rat liver during regeneration and after carbon tetrachloride intoxication. Hepatology. 1993, 18, 1202-1207.
130. L. Suarez, B. Vidriales, J. Garcia-Larana, A. Lopez, R. Martinez, V. Martin-Reina, M. Tormo, J. D. Gonzalez-San Miguel, E. Lavilla, R. Garcia-Boyero, A. Orfao, J. F. San Miguel, PETHEMA Cooperative Group: Multiparametric analysis of apoptotic and multi-drug resistance phenotypes according to the blast cell maturation stage in elderly patients with acute myeloid leukemia. Haematologica. 2001, 86, 1287-1295.
131. A. Pani, B. Batetta, M. Putzolu, F. Sanna, O. Spano, S. Piras, M. F. Mulas, R. R. Bonatesta, C. Amat di S. Filippo, L. Vargiu, T. Marceddu, L. Sanna, P. La Colla, S. Dessi: MDR1, cholesterol esterification and cell growth: A comparative study in normal and multidrug resistant KB cell lines. Cell Mol Life Sci. 2000, 57, 1094-1103.
132. R. R. Bonatesta, B. Batetta: Cholesterol esterification and MDR1-Pgp in lymphoblastic leukaemia cells: Functional relationships. In: Cell Growth and Cholesterol Esters. Eds. A. Pani, S. Dessì, Kluwer Academic/Plenum Publishers, New York (USA) 2004, pp. 72-80.
133. X. Du, I. Kristiana, J. Wong, A. J. Brown: Involvement of Akt in ER-to-Golgi transport of SCAP/SREBP: A link between a key cell proliferativa pathway and membrane synthesis. Mol Biol Cell. 2006, 17, 2735-2745.